Leaflet CIFOBAN 136mmol / l solution for infusion

Product code:
W68772001
Quantity:
8
Indicated for:
urinary alkalinization; metabolic acidosis
Route of administration:
infusion
Substance:
sodium citrate (electrolyte)
ATC
B05CB02 — Blood and blood forming organs | Irrigating solutions | Salt solutions
Sodium citrate is a compound used in medicine as a urinary alkalinizer, anticoagulant, and corrector of electrolyte imbalances. It works by increasing urine pH, preventing kidney stone formation, and reducing urinary tract irritation.

The medication is administered orally or intravenously, as directed by a doctor, depending on the condition being treated. It is important for patients to follow the prescribed dosage and undergo regular check-ups to monitor electrolyte balance.

Patients should be aware of potential side effects, such as nausea, diarrhea, or abdominal discomfort. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, diarrhea, and abdominal discomfort. In rare cases, severe reactions such as hypernatremia or metabolic alkalosis may occur. Patients should be informed of these risks before starting treatment.

General data about CIFOBAN 136mmol / l

Substance:
sodium citrate
Product code:
W68772001
Concentration:
136mmol / l
Pharmaceutical form:
solution for infusion
Quantity:
8
Product type:
Generic medicine
Prescription status:
S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.

Marketing authorisation

Manufacturer:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH - GERMANIA
Holder:
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH - GERMANIA
Number:
14396/2022/01
Shelf life:
2 years-after packaging for sale; after the first opening a pungii-it is used immediately